Skip to main content
. Author manuscript; available in PMC: 2017 Jun 16.
Published in final edited form as: Neuroepidemiology. 2016 Jun 16;47(1):11–17. doi: 10.1159/000446655

Table 1.

Demographic data and co-morbidities of 371 participants

PD ET Control p value
N 108 139 124
Age (years) 71.3 ± 6.4 (71.0) 71.9 ± 12.8 (73.0) 71.5 ± 9.1 (72.0) 0.12 a
Female gender 60 (55.6) 73 (52.5) 67 (54.0) 0.89 b
Education (years) 16.3 ± 2.8 (16.0) 16.1 ± 2.6 (16.0) 16.2 ± 2.7 (16.0) 0.61 a
Cigarette pack years 9.3 ± 17.8 (0.0) 11.4 ± 18.9 (1.0) 10.6 ± 16.1 (2.0) 0.21 a
BMI (kg/m2) 24.9 ± 5.7 (24.3) 25.3 ± 5.1 (25.0) 26.0 ± 7.0 (25.6) 0.35 a
Number of prescription medications 5.8 ± 2.8 (5.0) * 4.9 ± 3.2 (4.0) * 3.5 ± 2.9 (3.0) <0.001 a
Years since last hospitalization 11.5 ± 16.0 (4.0) 11.5 ± 16.4 (4.0) 12.4 ± 14.6 (7.0) 0.44 a
CIRS score 7.2 ± 3.2 (7.0) 7.3 ± 3.6 (7.0) 6.8 ± 3.9 (7.0) 0.48 a
Diabetes mellitus 9 (8.4) 11 (8.1) 14 (11.4) 0.62 b
Daily levodopa dosage (mg) 529.8 ± 394.7 NA NA NA

Values are mean ± standard deviation (median) or number (percentage)

a

Kruskal-Wallis test comparing all three groups

b

Chi-square test comparing all three groups

*

Significantly different from controls (p < 0.05, Mann-Whitney test)

BMI = Body Mass Index, CIRS = Cumulative Illness Rating Scale, ET = essential tremor, mg = milligrams, NA = not applicable, PD = Parkinson's disease